Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 CerecorArcturus TherapeuticsStrongbridge BiopharmaKala PharmaceuticalsAxovant Sciences
SymbolNASDAQ:CERCNASDAQ:ARCTNASDAQ:SBBPNASDAQ:KALANASDAQ:AXON
Price Information
Current Price$3.39$9.75$1.99$3.48$0.06
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$9.67$18.00$11.50$21.80$4.50
% Upside from Price Target185.15% upside84.62% upside477.89% upside526.44% upside7,658.62% upside
Trade Information
Market Cap$153.05 million$146.32 million$108.91 million$118.34 million$149.18 million
Beta2.112.320.812.141.21
Average Volume49,085101,186229,296273,5771,450,955
Sales & Book Value
Annual Revenue$18.33 million$15.75 million$18.03 millionN/AN/A
Price / Sales8.168.835.98N/AN/A
CashflowN/AN/A$0.83 per shareN/AN/A
Price / CashN/AN/A2.40N/AN/A
Book Value$0.51 per share$1.27 per share$2.42 per share$3.11 per share$0.19 per share
Price / Book6.657.680.82N/AN/A
Profitability
Net Income$-40,050,000.00$-21,780,000.00$31.85 million$-66,740,000.00$-221,570,000.00
EPSN/A($2.16)$0.31($2.48)($2.06)
Trailing P/E Ratio0.00N/A6.42N/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-231.68%-50.32%181.52%N/AN/A
Return on Equity (ROE)-143.30%-112.75%49.92%-117.68%-416.05%
Return on Assets (ROA)-42.73%-30.62%24.55%-52.43%-124.55%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.81%2.43%N/A1.16%1.24%
Current Ratio0.74%2.51%5.31%7.50%2.02%
Quick Ratio0.71%2.51%5.13%7.04%2.02%
Ownership Information
Institutional Ownership Percentage55.75%12.87%52.22%68.63%7.58%
Insider Ownership Percentage64.30%18.10%5.10%30.77%6.00%
Miscellaneous
Employees6472106130N/A
Shares Outstanding44.11 million14.27 million54.19 million34.01 million122.28 million
Next Earnings Date11/12/2019 (Estimated)11/6/2019 (Estimated)10/30/2019 (Estimated)11/14/2019 (Estimated)N/A
OptionableOptionableOptionableOptionableOptionableOptionable
 CerecorArcturus TherapeuticsStrongbridge BiopharmaKala PharmaceuticalsAxovant Sciences

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel